NetworkNewsBreaks

WednesdayApr 10, 2024 2:12 pm

NetworkNewsBreaks – OneMedNet Corporation (NASDAQ: ONMD) Moves to Solidify Cash Position, Accelerate Growth

OneMedNet (NASDAQ: ONMD) is the leading curator of regulatory-grade Real World Data (“iRWD(TM)”) through its proven OneMedNet iRWD(TM) solution. The company recently announced that it has entered into a definitive securities purchase agreement, dated as of March 28, 2024, with an institutional investor providing up to $4.54 million in funding through a private placement for the issuance of senior convertible notes. OneMedNet intends to use the net proceeds from the offering for working capital purposes. “This securities purchase agreement demonstrates confidence in our comprehensive iRWD(TM) platform, marking an important milestone for OneMedNet as we have the investment needed to expedite…

Continue Reading

WednesdayApr 10, 2024 2:03 pm

NetworkNewsBreaks – Why Life Electric Vehicles Holdings Inc. (LFEV) Is ‘One to Watch’

Life Electric Vehicles Holdings (OTC: LFEV) (d/b/a Life EV Group), together with its subsidiaries, is a developer, manufacturer and distributor in the light electric vehicle industry. Focusing on the launch, acquisition and consolidation of multiple brands of e-bikes, e-trikes, e-scooters and light EVs, the company aims to position itself as an industry leader for the American micro-mobility market “In addition to offering ready-to-ride electric vehicles, Life EV Group intends to distribute individual components, including motors, batteries, chargers, controllers and EV parts, to third-party manufacturers in both the U.S. and worldwide,” a recent article reads. “The company’s first acquisition was completed…

Continue Reading

WednesdayApr 10, 2024 1:04 pm

NetworkNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Eyes Significant Interest Since Full Launch of Evolve(TM)

SenesTech (NASDAQ: SNES), a rodent fertility control expert and the innovator of the only EPA-registered contraceptive for male and female rats, recently released its financial results for the 2023 financial year. “Of note was the 80% year-to-date (‘YTD’) revenue growth and the 45.2% year-over-year (‘YOY’) growth in gross profit, a significant milestone which Joel Fruendt, president and CEO of SenesTech, attributed to the development of Evolve(TM), the company’s all-new soft bait product,” a recent article reads. “Since the full launch of Evolve in January 2024, we have seen a significant uptick in interest and orders from a wide range of…

Continue Reading

WednesdayApr 10, 2024 12:41 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Chief Science Officer to Present at This Month’s Europe Dermatology Drug Development Summit

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices business unit, will be featured at this month’s annual Dermatology Drug Development Summit Europe. During the three-day gathering, SCNI chief science officer Dr. Tamar Ben-Yedidia will discuss the company’s NanoAbs as a local treatment for plaque psoriasis; Ben-Yedidia will be joined by Professor Michael Schön, director of the University Medical Center Göttingen's Department of Dermatology, Venereology & Allergology. The summit is scheduled for April 16–18, 2024, in Berlin; SCNI’s presentation is slated…

Continue Reading

WednesdayApr 10, 2024 9:15 am

NetworkNewsBreaks – Telo Genomics Corp. (TSX.V: TELO) (OTCQB: TDSGF) Notes Key Milestone with Award of College of American Pathologists Accreditation

Telo Genomics (TSX.V: TELO) (OTCQB: TDSGF),a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncology, has received accreditation for its Toronto-based laboratory at the MaRS Center from the Accreditation Committee of the College of American Pathologists (“CAP”). The accreditation followed more than a year of preparation and an on-site inspection by the CAP Accreditation Programs. CAP is the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, and its accreditation recognizes rigorous and robust standards. “The CAP accreditation highlights Telo Genomics' commitment and…

Continue Reading

TuesdayApr 09, 2024 3:46 pm

NetworkNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Moves Closer to Industrialization of E-Motion(TM) Product

Vision Marine Technologies Inc. (NASDAQ: VMAR), a leader in electric marine propulsion, today announced a groundbreaking achievement in electric outboard propulsion, in collaboration with McLaren Engineering, a division of Linamar Corporation. Aligning with the fast-evolving electric market and the upcoming SAE J1228 outboard compliance standard, Vision Marine has revolutionized the measurement of rated power output with its E-Motion(TM) 180E Electric Powertrain Systems. Vision Marine and McLaren Engineering have developed a sophisticated test cell, designed to meticulously control various critical parameters and provide a comprehensive and precise assessment of the powertrain system under conditions that mimic real-world usage. “We are excited…

Continue Reading

TuesdayApr 09, 2024 3:35 pm

NetworkNewsBreaks – InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Key Data in First-Ever Scientific Presentation of Proprietary HeartBeam AI

HeartBeam(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, is presenting new data at the European Heart Rhythm Association (“EHRA”) Conference. According to the announcement, this is the first scientific presentation on the company’s deep learning algorithm: HeartBeam AI. The data demonstrates that applying the company’s artificial intelligence (“AI”) algorithms to vectorcardiography (“VCG”) showed considerably improved performance in the detection of atrial flutter over single-lead electrocardiograms (“ECGs”) and similar performance to 12-lead ECGs, the standard for diagnosing atrial flutter. The company noted that the data indicates an opportunity for a VCG-based algorithm…

Continue Reading

TuesdayApr 09, 2024 3:10 pm

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Featured in Bell2Bell Podcast

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Thomas Ullrich, CEO of Aston Bay, joined the program to provide an introduction to Aston Bay and its business model. “Overall, Aston Bay is in the business of adding value through discovery of high-grade critical metals and precious metals deposits,” Ullrich said in the interview. “We’re an exploration stage company. Really…

Continue Reading

TuesdayApr 09, 2024 2:55 pm

NetworkNewsBreaks – SUIC Worldwide Holdings Ltd. (SUIC) Now Offers Beneway USA’s Revolutionary B2B2C System

SUIC Worldwide Holdings Ltd. (OTC: SUIC), a publicly traded technology company, is offering Beneway USA proprietary business-to-business-to-consumer (“B2B2C”) systems, which provides strategic planning functions and combines business financing solutions with inventory management system features; the system is designed to complement and boost sales as well as marketing channels of partner merchants, franchisees and suppliers around the world. According to the announcement, Beneway USA provides services for the global supply chain financing market, which is valued at an estimated $20 trillion. Beneway’s system works seamlessly with SUIC's proprietary B2C platform, resulting in a superior system that incorporates an “All-in-One” payment and…

Continue Reading

TuesdayApr 09, 2024 2:15 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes on $3.2M Public Offering

Flora Growth (NASDAQ: FLGC), a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000-plus points of distribution around the world, has closed on an underwritten public offering. The offering, which was comprised of 1.7 million common shares, resulted in $3.23 million in gross proceeds for Flora Growth, before deductions. Flora Growth plans to use the funds from the offering for general corporate and working capital needs. Aegis Capital Corp. acted as the sole book-running manager for the offering, which closed on April 8, 2024. In addition, the company announced that its CEO, Clifford…

Continue Reading